JP

Hiroyoshi Hidaka

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyoshi Hidaka. Retrieved from https://idiyas.com/inventor/hiroyoshi-hidaka-ity3ips6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Hiroyoshi Hidaka: Innovator in Quinoline Sulfonoamino Compounds

Introduction

Hiroyoshi Hidaka is a notable inventor from Japan, recognized for his contributions to the field of medicinal chemistry. His work primarily focuses on compounds that exhibit vessel smooth muscle relaxation activity. Despite having no patents registered under his name, his research has significant implications in pharmacology.

Latest Patents

Hidaka's most notable invention is related to Quinoline Sulfonoamino Compounds. This invention discloses a compound represented by a specific formula, where various groups are selected to enhance the compound's effectiveness. These compounds are known for their vessel smooth muscle relaxation activity, as well as their ability to inhibit platelet agglutination and various protein kinases.

Career Highlights

Throughout his career, Hiroyoshi Hidaka has worked with several companies, including Masatoshi Hagiwara. His research has contributed to advancements in understanding how certain compounds can affect vascular functions and muscle relaxation.

Collaborations

Hidaka has collaborated with notable coworkers such as Kenji Naitoh and Tadashi Toshioka. Their combined efforts have furthered research in the field of medicinal chemistry.

Conclusion

Hiroyoshi Hidaka's work in the development of Quinoline Sulfonoamino Compounds showcases his innovative approach to addressing vascular health issues. His contributions, although not patented, are valuable to the scientific community and highlight the importance of research in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…